awmsg logo



esketamine hydrochloride (Vesierra®)


Reference No. 2337

Publication date:
13/12/2013


Appraisal information

esketamine hydrochloride (Vesierra®) 5 mg/ml solution for injection


Company: Pfizer Ltd
BNF category: Anaesthesia
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 06/12/2013

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, esketamine hydrochloride (Vesierra®) cannot be endorsed for use within NHS Wales for the induction and maintenance of general anaesthesia, as the only anaesthetic or in combination with another anaesthetic, anesthesia and pain relief (analgesia) in emergency medicine and supplementation of regional or local anaesthesia.
Statement of Advice (SOA)
Download